A Study to Evaluate the Treatment Patterns and Clinical Outcomes of Pazopanib in Patients with Advanced Soft Tissue Sarcomas.
Latest Information Update: 13 Feb 2018
Price :
$35 *
At a glance
- Drugs Pazopanib (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms SPIRE
- 13 Feb 2018 New trial record